Ledger.Open graph →
SEC Form D · filed November 12, 2020

Equilibre BioPharmaceuticals Corp

Offering
$35.8M
Sold
$25.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Steven Gordon · New York, NYExecSam Waksal · New York, NYExecFrancois Maisonrouge · New York, NYDirectorJoel Marcus · Pasadena, CADirectorJoel Marcus · New York, NYDirectorDavid Friedman · Armonk, NYDirectorSteven Gordon · New York, NYExecSam Waksal · New York, NYExecFrancois Maisonrouge · New York, NYDirectorJoel Marcus · Durham, NCDirectorDavid Friedman · CHERRY HILL, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗